Evidence map›Paper›PMID 24670468›Full record

ArticlePloS one2014

A new species of mesonivirus from the Northern Territory, Australia.

David Warrilow, Daniel Watterson, Roy A Hall, Steven S Davis, Richard Weir, Nina Kurucz, Peter Whelan, Richard Allcock, Sonja Hall-Mendelin, Caitlin A O'Brien and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Insect-specific Alphamesonivirus-1 (Journal of virology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David WarrilowPublic Health Virology Laboratory, Forensic and Scientific Services, Department of Health, Archerfield, Queensland, Australia.
Daniel WattersonAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.
Roy A HallAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.
Steven S DavisBerrimah Veterinary Labs, Department of Primary Industries and Fisheries, Darwin, Northern Territory, Australia.
Richard WeirBerrimah Veterinary Labs, Department of Primary Industries and Fisheries, Darwin, Northern Territory, Australia.
Nina KuruczCentre for Disease Control, Health Protection Division, Northern Territory Department of Health, Darwin, Northern Territory, Australia.
Peter WhelanCentre for Disease Control, Health Protection Division, Northern Territory Department of Health, Darwin, Northern Territory, Australia.
Richard AllcockLotteryWest State Biomedical Facility, Genomics, School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Western Australia; Department of Clinical Immunology, Pathwest Laboratory Medicine Western Australia, Royal Perth Hospital, Perth, Western Australia, Australia.
Sonja Hall-MendelinPublic Health Virology Laboratory, Forensic and Scientific Services, Department of Health, Archerfield, Queensland, Australia.
Caitlin A O'BrienAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.
Jody Hobson-PetersAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we describe Casuarina virus (CASV), a new virus in the family Mesoniviridae. This is the first report of a mesonivirus in Australia, which extends the geographical range of this virus family to 3 continents. The virus was isolated in 2010 from Coquillettidia xanthogaster mosquitoes during surveillance in the suburbs of Darwin, the capital of the Northern Territory. Cryo-electron microscopy of the CASV virions revealed spherical particles of 65 nm in size with large club-shaped projections of approximately 15 nm in length. The new virus was most closely related to Alphamesonivirus 1, the only currently recognized species in the family. In 2013 a further 5 putative new mesonivirus species were described: Hana, Méno, Nsé, Moumo and Dak Nong viruses. The evolutionary distance between CASV and two of its closest relatives, Cavally and Hana viruses (Jones-Taylor-Thornton distance of 0.151 and 0.224, respectively), along with its isolation from a different genus of mosquitoes captured on a separate continent indicate that CASV is a new species.

Indexed as

AnimalsCell LineComputer SimulationCryoelectron MicroscopyCulicidaeNidoviralesNorthern TerritoryPhylogenyProtein Structure, TertiaryRNA-Dependent RNA PolymeraseSequence Homology, Amino AcidSpecies SpecificityViral ProteinsVirionVirus ReplicationRNA-Dependent RNA PolymeraseViral Proteins

Identifiers

PMID24670468
PMCPMC3966781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.